Allogeneic Bone Marrow Transplantation After High-Dose Busulfan and Cyclophosphamide in Patients With Acute Nonlymphocytic Leukemia

Ninety-nine patients with acute nonlymphocytic leukemia (ANLL) received HLA-identical bone marrow transplants (BMTs) from sibling donors after preparation with high doses of busulfan and cyclophosphamide. Forty-nine patients were transplanted in first complete remission (CR), and 50 patients were tr...

Full description

Saved in:

Bibliographic Details
Published in:	Blood 1989-06, Vol.73 (8), p.2209-2218
Main Authors:	Geller, Robert B., Saral, Rein, Piantadosi, Steven, Zahurak, Marianna, Vogelsang, Georgia B., Wingard, John R., Ambinder, Richard F., Beschorner, William B., Braine, Hayden G., Burns, William H., Hess, Allan D., Jones, Richard J., May, W. Stratford, Rowley, Scott D., Wagner, John E., Yeager, Andrew M., Santos, George W.
Format:	Article
Language:	English
Subjects:	Acute Disease Biological and medical sciences Bone Marrow Transplantation Busulfan - therapeutic use Cyclophosphamide - therapeutic use Drug Administration Schedule Graft Survival Graft vs Host Disease - prevention & control Hematologic and hematopoietic diseases Humans Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - surgery Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Postoperative Complications - prevention & control Premedication Prognosis Recurrence Remission Induction
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!